Undetected safety signals become regulatory findings. Jeyflex provides end-to-end signal detection and management services that combine advanced data analytics with expert medical review, so your company can identify emerging risks early, manage them systematically, and stay fully compliant with GVP Module IX and local African regulatory requirements.
Identification and Evaluation of Drug Safety Signals
Is Your Safety Signal Management Process Audit-Ready?
What is Signal Detection in Pharmacovigilance?
Signal detection in pharmacovigilance is the process of identifying new or changing safety information associated with a medicinal product. A safety signal may indicate a previously unknown adverse reaction, a change in the frequency or severity of a known adverse event, or a new risk factor affecting patient safety.
Regulatory authorities globally expect Marketing Authorization Holders to maintain a documented, systematic approach to signal detection, validation, assessment, and communication. Without it, risks escalate undetected until they become inspection findings or patient safety events.
Signals can emerge from:
Jeyflex combines quantitative detection methods with expert medical review, ensuring every signal is evaluated in context before any action is recommended.
The Signal Management Lifecycle
We follow a structured, audit-ready workflow compliant with GVP Module IX from initial detection through to documented regulatory action.
01
Signal Detection
We continuously monitor diverse data sources, including ICSRs, spontaneous reports, medical literature, and regulatory databases such as EudraVigilance and FAERS, to identify potential safety signals early.
02
Signal Validation
Not every alert is a risk. Our medical experts perform initial triage to distinguish between statistical noise and genuine safety concerns, ruling out known side effects and non-causal events before resources are committed.
03
Analysis & Prioritisation
Validated signals are assessed against clinical significance, frequency, severity, and regulatory reporting obligations, prioritized to ensure the most critical risks receive immediate attention.
04
Signal Assessment
A deep-dive medical review evaluating clinical data, pharmacological properties, and non-clinical studies to confirm the benefit-risk profile and determine whether regulatory action is required.
05
Recommendation for Action
We provide clear, actionable outcomes whether updating the SmPC, issuing a Dear Healthcare Professional letter, amending the RMP, or submitting a regulatory safety report.
06
Signal Tracking & Lifecycle Management
Every signal is tracked through its full lifecycle, from initial detection to closure, with complete documentation maintained for inspection and audit purposes at all times.
Signal Detection and Risk Management Integration
Signal detection and risk management are inseparable; you cannot manage a risk you have not detected. New safety information identified through signal detection often leads directly to updates across your broader pharmacovigilance and risk management framework.
Signal findings feed directly into:
Our experts ensure identified signals are incorporated into your full risk management framework so the entire system stays current, consistent, and inspection-ready.
Why Choose Jeyflex for Signal Detection and Management?
Our Signal Management Services
Jeyflex provides end-to-end signal management services supporting both global and local pharmacovigilance requirements.
The Regulatory Risk of Inadequate Signal Management
Companies without a systematic signal management process face increasing regulatory exposure:
A documented, systematic signal management process is not optional; it is a regulatory expectation under GVP Module IX and the equivalent requirements of African NRAs.
Frequently Asked Questions
Yes. We conduct gap assessments, review existing signal management documentation, and implement corrective actions to strengthen compliance with GVP Module IX requirements. We can also develop SOPs, templates, and governance processes to support inspection readiness — and conduct a retrospective review of your data to close existing gaps.
Absolutely. We provide fully outsourced and hybrid signal management services, allowing your team to focus on strategic activities while we manage routine signal detection, validation, assessment, and documentation. We can act as your full PV department or as an extension of your existing team — depending on your operational needs.
Our approach combines statistical detection methods — including Disproportionality Analysis — with expert medical review. This ensures that potential signals are evaluated within the appropriate clinical context, reducing unnecessary investigations while maintaining patient safety. The result is a more focused, efficient signal management process with fewer false positives.
Yes. We provide signal detection and management support for products registered across African markets — including compliance with the specific requirements of PPB, NDA, EFDA, RFDA, TMDA, NAFDAC, SAHPRA, and other African national regulatory authorities alongside global GVP Module IX standards.
Signal detection is the process of identifying a potential new safety concern from data sources. Signal management is the broader process that covers the full lifecycle — from detection through validation, analysis, assessment, recommendation for action, implementation, and documentation. Jeyflex provides both as an integrated service, ensuring detected signals are never left unmanaged.
Ready to Strengthen Your Signal Detection and Management Process?
Speak with our pharmacovigilance experts today to discover how our signal detection and management services can help you achieve compliance, improve patient safety, and support successful regulatory outcomes across Africa.